|
Age, years
|
71.4 ± 11.8
|
71.7 ± 12.1
|
0.89
|
|
Male sex, no. (%)
|
55 (69.6)
|
46 (76.7)
|
0.36
|
|
Smokers, no. (%)
|
43 (54.4)
|
34 (56.7)
|
0.79
|
|
Body mass index ± SD
|
24.1 ± 3.1
|
23.7 ± 2.6
|
0.25
|
|
VAS score
|
34.1 ± 11.1
|
32.3 ± 16.1
|
0.54
|
|
Percent predicted FEV1, %†
|
58.0 ± 14.8
|
55.8 ± 16.1
|
0.42
|
|
Percent predicted FVC, %†
|
71.3 ± 17.1
|
72.1 ± 18.2
|
0.47
|
|
Comorbidities, no. (%)
|
|
Ischemic heart disease
|
31 (39.2)
|
27 (45.0)
|
0.52
|
|
Heart failure
|
20 (25.3)
|
13 (21.7)
|
0.63
|
|
Diabetes mellitus
|
11 (13.9)
|
10 (16.7)
|
0.46
|
|
Lung cancer
|
2 (2.5)
|
6 (10.0)
|
0.21
|
|
WBC
|
|
1. > 10 × 109/L, no. (%)
|
42 (53.1)
|
34 (56.7)
|
0.52
|
|
C-reactive protein (mg/L), median (IQR)
|
46.0 (12–124)
|
44.8 (18–113)
|
0.73
|
|
PaO2 (mm Hg), median (IQRs)
|
71.7 (41–99)
|
72.8 (43–115)
|
0.72
|
|
PaCO2 (mm Hg), median (IQRs)
|
42.8 (27–90)
|
40.9 (25–82)
|
0.45
|
|
ICS, no. (%)
|
76 (96.2)
|
59 (98.3)
|
0.08
|
|
SCS, course for current AECOPD, no. (%)
|
30 (37.9)
|
22 (36.7)
|
0.34
|
